Identified as
  • v4.0.2
  • FAQ
  • SIGN UP / LOGIN
  • LOGIN

Pivotal bioVenture Partners

San Francisco, California
cb
Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies
Founded:2017
Firm Location:San Francisco, California • Cambridge, Massachusetts • China • Stanford, California • San Francisco Bay Area
Investor Firms That Co-Invest with Pivotal bioVenture Partners
SR OneRA CapitalJohnson & Johnson InnovationF-Prime Capital PartnersDomain AssociatesLongitude CapitalNovo VenturesThe Column GroupAtlas VentureAvalon VenturesRiverVestDCVC (Data Collective)Sofinnova InvestmentsForbionArix BioscienceSR One Capital ManagementBVCF (Bioveda China Fund)Osage University PartnersEarlybird Venture CapitalMaveronSoffinova PartnersRed Tree Venture CapitalVersant VenturesCanaan PartnersOrbiMedEQT Life SciencesDimension Capital
Pivotal bioVenture Partners Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Glenn Batchelder, Venture Partner at Pivotal bioVenture Partners
Glenn Batchelder
Pivotal bioVenture PartnersVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Cambridge (MA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed)
+4
Photo of Peter Bisgaard, Managing Director at Pivotal bioVenture Partners
Peter Bisgaard
Pivotal bioVenture PartnersManaging Director
n/a
$1.5M
($100K - $5.0M)
Investors in SF Bay Area (CA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B)
+1
Photo of Joseph Charalel, Senior Associate at Pivotal bioVenture Partners
Joseph Charalel
Pivotal bioVenture PartnersSenior Associate
n/a
$1.5M
($100K - $5.0M)
Investors in Stanford (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed)
+8
Photo of Vincent Cheung, Managing Director at Pivotal bioVenture Partners
Vincent Cheung
Pivotal bioVenture PartnersManaging Director
n/a
$1.5M
($100K - $5.0M)
Investors in China
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Real Estate/PropTech (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Series A), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
+8
Photo of Rob Hopfner, Managing Partner at Pivotal bioVenture Partners
Rob Hopfner
Pivotal bioVenture PartnersManaging Partner
n/a
$1.5M
($100K - $5.0M)
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B)
+8
Photo of Ash Khanna, Partner at Pivotal bioVenture Partners
Ash Khanna
Pivotal bioVenture PartnersPartner
n/a
$1.5M
($100K - $5.0M)
Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
+8
Photo of Jennifer Lee, Partner at Pivotal bioVenture Partners
Jennifer Lee
Pivotal bioVenture PartnersPartner
n/a
$1.5M
($100K - $5.0M)
Investors in SF Bay Area (CA)
Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+16
Photo of Benjamin Li, Senior Associate at Pivotal bioVenture Partners
Benjamin Li
Pivotal bioVenture PartnersSenior Associate
n/a
$1.5M
($100K - $5.0M)
Investors in San Francisco (CA)
Investors in BioTech (Series B), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series B)
Photo of David Malek, Venture Partner at Pivotal bioVenture Partners
David Malek
Pivotal bioVenture PartnersVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in San Francisco (CA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed)
+8
Photo of Brian Mills, Senior Associate at Pivotal bioVenture Partners
Brian Mills
Pivotal bioVenture PartnersSenior Associate
n/a
$1.5M
($100K - $5.0M)
Investors in SF Bay Area (CA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A)
Photo of Qian Wang, Principal at Pivotal bioVenture Partners
Qian Wang
Pivotal bioVenture PartnersPrincipal
n/a
$1.5M
($100K - $5.0M)
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
+4
Copyright © 2025NFX Capital. We invest.
FAQ Terms Privacy Disclosure
Log in for full access to the Signal investing network

Unlock your intro paths to 30,000+ Pre-Seed, Seed, and Serias A investors. It's free.

Or sign up or log in with email